These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23807360)

  • 41. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants.
    Vesikari T; Karvonen A; Korhonen T; Espo M; Lebacq E; Forster J; Zepp F; Delem A; De Vos B
    Vaccine; 2004 Jul; 22(21-22):2836-42. PubMed ID: 15246619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
    Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
    Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
    Linhares AC; Velázquez FR; Pérez-Schael I; Sáez-Llorens X; Abate H; Espinoza F; López P; Macías-Parra M; Ortega-Barría E; Rivera-Medina DM; Rivera L; Pavía-Ruz N; Nuñez E; Damaso S; Ruiz-Palacios GM; De Vos B; O'Ryan M; Gillard P; Bouckenooghe A;
    Lancet; 2008 Apr; 371(9619):1181-9. PubMed ID: 18395579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.
    Cunliffe N; Zaman K; Rodrigo C; Debrus S; Benninghoff B; Pemmaraju Venkata S; Han HH
    BMC Pediatr; 2014 Nov; 14():295. PubMed ID: 25433534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
    Middleton BF; Jones MA; Waddington CS; Danchin M; McCallum C; Gallagher S; Leach AJ; Andrews R; Kirkwood C; Cunliffe N; Carapetis J; Marsh JA; Snelling T
    BMJ Open; 2019 Nov; 9(11):e032549. PubMed ID: 31727664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
    Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
    Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of human rotavirus vaccine on severe diarrhea in African infants.
    Madhi SA; Cunliffe NA; Steele D; Witte D; Kirsten M; Louw C; Ngwira B; Victor JC; Gillard PH; Cheuvart BB; Han HH; Neuzil KM
    N Engl J Med; 2010 Jan; 362(4):289-98. PubMed ID: 20107214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.
    Lazarus RP; John J; Shanmugasundaram E; Rajan AK; Thiagarajan S; Giri S; Babji S; Sarkar R; Kaliappan PS; Venugopal S; Praharaj I; Raman U; Paranjpe M; Grassly NC; Parker EPK; Parashar UD; Tate JE; Fleming JA; Steele AD; Muliyil J; Abraham AM; Kang G
    Vaccine; 2018 Jan; 36(2):273-279. PubMed ID: 28874323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
    Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
    Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.
    Justino MC; Araújo EC; van Doorn LJ; Oliveira CS; Gabbay YB; Mascarenhas JD; Miranda YS; Guerra Sde F; Silva VB; Linhares AC
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):846-53. PubMed ID: 23147138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.
    Cheuvart B; Neuzil KM; Steele AD; Cunliffe N; Madhi SA; Karkada N; Han HH; Vinals C
    Hum Vaccin Immunother; 2014; 10(2):505-11. PubMed ID: 24240068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
    Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
    Cohet C; Cheuvart B; Moerman L; Bi D; Caplanusi A; Kariyappa M; Lalwani S; Mitra M; Sapru A; Saha S; Varughese PV; Kompithra RZ; Gandhi S
    Hum Vaccin Immunother; 2021 Nov; 17(11):4646-4653. PubMed ID: 34428112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period.
    Armah GE; Kapikian AZ; Vesikari T; Cunliffe N; Jacobson RM; Burlington DB; Ruiz LP
    J Infect Dis; 2013 Aug; 208(3):423-31. PubMed ID: 23599316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Vesikari T; Matson DO; Dennehy P; Van Damme P; Santosham M; Rodriguez Z; Dallas MJ; Heyse JF; Goveia MG; Black SB; Shinefield HR; Christie CD; Ylitalo S; Itzler RF; Coia ML; Onorato MT; Adeyi BA; Marshall GS; Gothefors L; Campens D; Karvonen A; Watt JP; O'Brien KL; DiNubile MJ; Clark HF; Boslego JW; Offit PA; Heaton PM;
    N Engl J Med; 2006 Jan; 354(1):23-33. PubMed ID: 16394299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.
    Bar-Zeev N; Kapanda L; Tate JE; Jere KC; Iturriza-Gomara M; Nakagomi O; Mwansambo C; Costello A; Parashar UD; Heyderman RS; French N; Cunliffe NA;
    Lancet Infect Dis; 2015 Apr; 15(4):422-8. PubMed ID: 25638521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth.
    Lu CY; Chang LY; Shao PL; Suryakiran PV; Han HH; Huang LM
    J Formos Med Assoc; 2013 Sep; 112(9):574-7. PubMed ID: 24079716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.